NYSE 100 undervalued ranking
Ranked by the Rule of 40 strategy. Lower valuation ranks higher. · Healthcare
Data as of: 2026-10-30 · end-of-day, not real-time
Information & education only — not investment advice or a guarantee of returns.
Best Undervalued NYSE 100 Stocks (2026) →
Best Balanced NYSE 100 Stocks (2026) →
💡 Preset screens
Rule of 40 — Growing software where growth + margin ≥ 40
Built from: Rule of 40 · EV/Sales · FCF Yield
Details →15 stocks · 1 value-trap stocks hidden
Return periodtrading days (holidays excluded)
Sort
1Lilly (Eli)LLY NYSE · HealthcareP/E47.697.2①
Mkt Cap
$1.26T
P/E
47.6
P/B
47.8
1M
+24.0%
2Bristol Myers SquibbBMY NYSE · HealthcareP/E13.865.3①
Mkt Cap
$127.7B
P/E
13.8
P/B
6.9
1M
+2.2%
3PfizerPFE NYSE · HealthcareP/E40.257.2
Mkt Cap
$174.0B
P/E
40.2
P/B
2.0
1M
+9.8%
4Merck & Co.MRK NYSE · HealthcareP/E118.756.9
Mkt Cap
$368.9B
P/E
118.7
P/B
8.8
1M
+3.6%
5MedtronicMDT NYSE · HealthcareP/E23.755.7
Mkt Cap
$123.5B
P/E
23.7
P/B
2.5
1M
+11.8%
6Stryker CorporationSYK NYSE · HealthcareP/E30.251.0
Mkt Cap
$111.9B
P/E
30.2
P/B
5.0
1M
+6.0%
7AbbVieABBV NYSE · HealthcareP/E83.350.1①
Mkt Cap
$521.1B
P/E
83.3
P/B
–
1M
+12.9%
8Elevance HealthELV NYSE · HealthcareP/E17.849.8
Mkt Cap
$91.1B
P/E
17.8
P/B
2.0
1M
+8.7%
9CVS HealthCVS NYSE · HealthcareP/E23.848.2
Mkt Cap
$115.4B
P/E
23.8
P/B
1.4
1M
+5.1%
10McKessonMCK NYSE · HealthcareP/E26.747.0①
Mkt Cap
$116.0B
P/E
26.7
P/B
–
1M
+10.2%
11UnitedHealth GroupUNH NYSE · HealthcareP/E23.246.1
Mkt Cap
$365.3B
P/E
23.2
P/B
3.5
1M
+9.4%
12HCA HealthcareHCA NYSE · HealthcareP/E15.740.8
Mkt Cap
$102.4B
P/E
15.7
P/B
–
1M
+10.9%
13Johnson & JohnsonJNJ NYSE · HealthcareP/E41.535.8
Mkt Cap
$657.7B
P/E
41.5
P/B
8.1
1M
+6.7%
14Danaher CorporationDHR NYSE · HealthcareP/E38.432.0
Mkt Cap
$163.3B
P/E
38.4
P/B
3.0
1M
+8.5%
15Thermo Fisher ScientificTMO NYSE · HealthcareP/E36.830.4
Mkt Cap
$257.7B
P/E
36.8
P/B
4.7
1M
+6.4%